N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine—A Review

Pediatric oncology is a critical area where the more efficient development of new treatments is urgently needed. The speed of approval of new drugs is still limited by regulatory requirements and a lack of innovative designs appropriate for trials in children. Childhood cancers meet the criteria of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michal Kyr, Adam Svobodnik, Radka Stepanova, Renata Hejnova
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/e362beda12c3412aac9b32d23e3902c8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!